Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Hyperaccelerated Award/Mechanisms in Immunomodulation Trials - Addendum to RFA-AI-04-001
Release Date: June 12, 2004
Announcement Number: NOT-AI-04-036
Funding Contact: Ursula Utz, Ph.D.
Program Area: Neural Environment
Also See:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-001.html
Brief Description:
The participating Institutes intend to commit approximately $1,100,000 in FY 2005 to fund 3 to 4 new grants for immune mechanistic,
ancillary studies of immunomodulatory interventions for immune system mediated diseases clinical trials and of vaccine clinical
trials for non-HIV/AIDS infectious diseases. NIAID does not have specified funds committed in FY 2005 as were available in
FY 2004 for immune mechanistic ancillary studies of vaccine clinical trials for the prevention and treatment NIAID Category
A, B and C agents of bioterrorism and non-HIV/AIDS emerging/re-emerging infectious diseases, however, these applications
are responsive to this RFA.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |